{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:12:58Z","timestamp":1789560778078,"version":"build-2803163510"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sarcoidosis is a multisystem granulomatous disease of uncertain etiology that most often involves the lungs and skin, though nearly any organ may be affected. Pulmonary disease typically manifests as bilateral hilar lymphadenopathy with diffuse interstitial infiltrates, whereas cutaneous involvement is reported in about 25%\u201335% of cases, presenting as erythema nodosum, plaques, nodules, or lupus pernio. Acute onset of extensive pulmonary infiltrates with cutaneous lesions other than erythema nodosum is uncommon and frequently misdirects clinicians toward infectious or malignant causes, particularly in tuberculosis-endemic regions. We describe a 35-year-old previously healthy male who presented with sudden dyspnea, persistent cough, and erythematous plaques and nodules on the extremities. Chest imaging revealed diffuse bilateral infiltrates with mediastinal lymphadenopathy, and laboratory findings showed elevated serum angiotensin-converting enzyme levels. Pulmonary function testing demonstrated a restrictive pattern with impaired diffusion capacity, while bronchoalveolar lavage revealed lymphocytosis with a CD4\/CD8 ratio above 3.5. Skin biopsy confirmed noncaseating granulomas, establishing the diagnosis of sarcoidosis with pulmonary and cutaneous involvement. The patient was started on oral corticosteroid therapy with prednisone 60 mg daily, gradually tapered according to clinical response. Within 2 weeks, there was marked improvement in respiratory symptoms and regression of skin lesions, leaving only residual pigmentation. Follow-up lung function and imaging demonstrated near-complete resolution, and steroids were successfully discontinued after 6 months without recurrence. This case highlights the importance of recognizing sarcoidosis in acute pulmonary\u2013cutaneous presentations, where timely diagnosis and corticosteroid therapy can lead to excellent outcomes.<\/jats:p>","DOI":"10.4103\/aam.aam_795_25","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:00:13Z","timestamp":1784185213000},"page":"S392-S396","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Rare Presentation of Sarcoidosis: A Case of Acute Onset Bilateral Pulmonary Infiltrates and Skin Lesions"],"prefix":"10.4103","volume":"25","author":[{"given":"Kishor","family":"Khilare","sequence":"first","affiliation":[{"name":"Department of General Medicine, Dr. D. Y. Patil Medical College and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanvi Vikas Rajeev","family":"Tale","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Dr. D. Y. Patil Medical College and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0037-1602845","article-title":"Sarcoidosis around the globe","volume":"38","author":"Mateyo","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"101283","DOI":"10.1016\/j.lanepe.2025.101283","article-title":"Incidence, prevalence, and mortality of sarcoidosis in England: A population-based study","volume":"53","author":"Bechman","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: A comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.rdc.2013.02.007","article-title":"Extrapulmonary manifestations of sarcoidosis","volume":"39","author":"Rao","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"1150751","DOI":"10.3389\/fmed.2023.1150751","article-title":"Differential diagnosis of pulmonary sarcoidosis: A review","volume":"10","author":"Valeyre","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.berh.2016.07.001","article-title":"Sarcoidosis: Rheumatology perspective","volume":"30","author":"Yee","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12016-015-8475-x","article-title":"Diagnosis of sarcoidosis","volume":"49","author":"Wessendorf","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of Sarcoidosis","volume":"28","author":"Rosen","year":"2007","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and treatment of pulmonary sarcoidosis: A review","volume":"327","author":"Belperio","year":"2022","journal-title":"JAMA"},{"key":"R12-20260916","first-page":"37","article-title":"Diagnosis issues in sarcoidosis","volume":"77","author":"Jeny","year":"2020","journal-title":"Respir Med Res"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"240228","DOI":"10.1183\/20734735.0228-2024","article-title":"A case of pulmonary and cutaneous sarcoidosis","volume":"21","author":"Foley","year":"2025","journal-title":"Breathe (Sheff)"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdcr.2024.05.019","article-title":"A case of cutaneous sarcoidosis with pulmonary involvement after SARS-CoV-2 mRNA vaccination","volume":"50","author":"Seol","year":"2024","journal-title":"JAAD Case Rep"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12890-024-03428-5","article-title":"CD4\/CD8 T-cell ratio in bronchoalveolar lavage fluid as a marker of sarcoidosis severity: A retrospective study","volume":"25","author":"Zannese","year":"2025","journal-title":"BMC Pulm Med"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"1319931","DOI":"10.3389\/fdsfr.2023.1319931","article-title":"Safety of corticosteroid therapy in sarcoidosis treatment","volume":"3","author":"Di Marco Berardino","year":"2023","journal-title":"Front Drug Saf Regul"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4103\/lungindia.lungindia_499_24","article-title":"Five principles and protocols for the clinician based on the 2021 ERS and BTS statements for treating sarcoidosis","volume":"41","author":"Dhooria","year":"2024","journal-title":"Lung India"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"2300198","DOI":"10.1183\/13993003.00198-2023","article-title":"High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: A randomised trial (SARCORT trial)","volume":"62","author":"Dhooria","year":"2023","journal-title":"Eur Respir J"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/0378-6323.93661","article-title":"Pulmonary and cutaneous sarcoidosis in a treated case of renal tuberculosis","volume":"78","author":"Gupta","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_795_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:00:47Z","timestamp":1789560047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_795_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":17,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_795_25","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"2025-12-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}